Thioredoxin reductase 1 suppresses adipocyte differentiation and insulin responsiveness

Scientific Reports

Volumn 6, Issue , 2016, Pages

  Peng, Xiaoxiao ^a,e   Giménez Cassina, Alfredo ^a,b   Petrus, Paul ^c   Conrad, Marcus ^d   Rydén, Mikael ^c   Arnér, Elias S J ^a  

^a KAROLINSKA INSTITUTE   (Sweden)

^b UNIVERSIDAD AUTÓNOMA DE MADRID   (Spain)

^c KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^d INSTITUTE OF EPIDEMIOLOGY   (Germany)

^e ASTRAZENECA R AND D   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

THIOREDOXIN REDUCTASE 1; TXNRD1 PROTEIN, HUMAN; TXNRD1 PROTEIN, MOUSE;

ADIPOCYTE; ADIPOGENESIS; ANIMAL; CELL DIFFERENTIATION; ENZYMOLOGY; FEMALE; GENETICS; HUMAN; INSULIN RESISTANCE; KNOCKOUT MOUSE; METABOLISM; MOUSE; TRANSFORMED CELL LINE;

ADIPOCYTES; ADIPOGENESIS; ANIMALS; CELL DIFFERENTIATION; CELL LINE, TRANSFORMED; FEMALE; HUMANS; INSULIN RESISTANCE; MICE; MICE, KNOCKOUT; THIOREDOXIN REDUCTASE 1;

EID: 84976615559     PISSN: None     EISSN: 20452322     Source Type: Journal    
DOI: 10.1038/srep28080     Document Type: Article

References (70)

1. Spalding, K. L. et al. Dynamics of fat cell turnover in humans. Nature 453, 783-787 (2008).
2. Umek, R. M., Friedman, A. D. & McKnight, S. L. CCAAT-enhancer binding protein: A component of a differentiation switch. Science 251, 288-292 (1991).
3. Rosen, E. D. & MacDougald, O. A. Adipocyte differentiation from the inside out. Nat Rev Mol Cell Biol 7, 885-896 (2006).
4. Rosen, E. D., Walkey, C. J., Puigserver, P. & Spiegelman, B. M. Transcriptional regulation of adipogenesis. Genes Dev 14, 1293-1307 (2000).
5. Tseng, Y. H., Kriauciunas, K. M., Kokkotou, E. & Kahn, C. R. Differential roles of insulin receptor substrates in brown adipocyte differentiation. Molecular and cellular biology 24, 1918-1929 (2004).
6. Laustsen, P. G. et al. Lipoatrophic diabetes in Irs1(-/-)/Irs3(-/-) double knockout mice. Genes Dev 16, 3213-3222 (2002).
7. Garofalo, R. S. et al. Severe diabetes, age-dependent loss of adipose tissue, and mild growth deficiency in mice lacking Akt2/PKB beta. J Clin Invest 112, 197-208 (2003).
8. Arnér, E. S. Focus on mammalian thioredoxin reductases-important selenoproteins with versatile functions. Biochim Biophys Acta 1790, 495-526 (2009).
9. Bondareva, A. A. et al. Effects of thioredoxin reductase-1 deletion on embryogenesis and transcriptome. Free radical biology & medicine 43, 911-923 (2007).
10. Jakupoglu, C. et al. Cytoplasmic thioredoxin reductase is essential for embryogenesis but dispensable for cardiac development. Mol Cell Biol 25, 1980-1988 (2005).
11. Iverson, S. V. et al. A Txnrd1-dependent metabolic switch alters hepatic lipogenesis, glycogen storage, and detoxification. Free radical biology & medicine 63, 369-380 (2013).
12. Carlson, B. A. et al. Thioredoxin reductase 1 protects against chemically induced hepatocarcinogenesis via control of cellular redox homeostasis. Carcinogenesis 33, 1806-1813 (2012).
13. Saeed, H., Taipaleenmaki, H., Aldahmash, A. M., Abdallah, B. M. & Kassem, M. Mouse embryonic fibroblasts (MEF) exhibit a similar but not identical phenotype to bone marrow stromal stem cells (BMSC). Stem Cell Rev 8, 318-328 (2012).
14. Mandal, P. K. et al. Loss of thioredoxin reductase 1 renders tumors highly susceptible to pharmacologic glutathione deprivation. Cancer Res 70, 9505-9514 (2010).
15. Peng, X. et al. Sec-containing TrxR1 is essential for self-sufficiency of cells by control of glucose-derived H2O2. Cell Death Dis 5, e1235 (2014).
16. Ross, S. E. et al. Inhibition of adipogenesis by Wnt signaling. Science 289, 950-953 (2000).
17. Tang, Q. Q., Otto, T. C. & Lane, M. D. Mitotic clonal expansion: A synchronous process required for adipogenesis. P Natl Acad Sci USA 100, 44-49 (2003).
18. Tang, Q. Q., Otto, T. C. & Lane, M. D. CCAAT/enhancer-binding protein beta is required for mitotic clonal expansion during adipogenesis. P Natl Acad Sci USA 100, 850-855 (2003).
19. Lechner, S., Mitterberger, M. C., Mattesich, M. & Zwerschke, W. Role of C/EBPbeta-LAP and C/EBPbeta-LIP in early adipogenic differentiation of human white adipose-derived progenitors and at later stages in immature adipocytes. Differentiation 85, 20-31 (2013).
20. Taniguchi, C. M., Emanuelli, B. & Kahn, C. R. Critical nodes in signalling pathways: insights into insulin action. Nat Rev Mol Cell Biol 7, 85-96 (2006).
21. Du, K. & Montminy, M. CREB is a regulatory target for the protein kinase Akt/PKB. The Journal of biological chemistry 273, 32377-32379 (1998).
22. Reusch, J. E., Colton, L. A. & Klemm, D. J. CREB activation induces adipogenesis in 3T3-L1 cells. Molecular and cellular biology 20, 1008-1020 (2000).
23. Shaywitz, A. J. & Greenberg, M. E. CREB: A stimulus-induced transcription factor activated by a diverse array of extracellular signals. Annual review of biochemistry 68, 821-861 (1999).
24. Kim, J. E. & Chen, J. regulation of peroxisome proliferator-Activated receptor-gamma activity by mammalian target of rapamycin and amino acids in adipogenesis. Diabetes 53, 2748-2756 (2004).
25. Porstmann, T. et al. SREBP activity is regulated by mTORC1 and contributes to Akt-dependent cell growth. Cell Metab 8, 224-236 (2008).
26. Dagnell, M. et al. Selective activation of oxidized PTP1B by the thioredoxin system modulates PDGF-beta receptor tyrosine kinase signaling. P Natl Acad Sci USA 110, 13398-13403 (2013).
27. Elchebly, M. et al. Increased insulin sensitivity and obesity resistance in mice lacking the protein tyrosine phosphatase-1B gene. Science 283, 1544-1548 (1999).
28. Tamguney, T. & Stokoe, D. New insights into PTEN. Journal of cell science 120, 4071-4079 (2007).
29. Stambolic, V. et al. Regulation of PTEN transcription by p53. Mol Cell 8, 317-325 (2001).
30. Tang, Y. & Eng, C. PTEN autoregulates its expression by stabilization of p53 in a phosphatase-independent manner. Cancer research 66, 736-742 (2006).
31. Moos, P. J., Edes, K., Cassidy, P., Massuda, E. & Fitzpatrick, F. A. Electrophilic prostaglandins and lipid aldehydes repress redoxsensitive transcription factors p53 and hypoxia-inducible factor by impairing the selenoprotein thioredoxin reductase. The Journal of biological chemistry 278, 745-750 (2003).
32. Meuillet, E. J., Mahadevan, D., Berggren, M., Coon, A. & Powis, G. Thioredoxin-1 binds to the C2 domain of PTEN inhibiting PTENs lipid phosphatase activity and membrane binding: A mechanism for the functional loss of PTENs tumor suppressor activity. Archives of biochemistry and biophysics 429, 123-133 (2004).
33. Lee, S. R. et al. Reversible inactivation of the tumor suppressor PTEN by H2O2. The Journal of biological chemistry 277, 20336-20342 (2002).
34. Schwertassek, U. et al. Reactivation of oxidized PTP1B and PTEN by thioredoxin 1. Febs J 281, 3545-3558 (2014).
35. Kanda, Y., Hinata, T., Kang, S. W. & Watanabe, Y. Reactive oxygen species mediate adipocyte differentiation in mesenchymal stem cells. Life Sci 89, 250-258 (2011).
36. Samuni, Y., Goldstein, S., Dean, O. M. & Berk, M. The chemistry and biological activities of N-Acetylcysteine. Biochimica et biophysica acta 1830, 4117-4129 (2013).
37. Polyak, K. et al. Cloning of p27Kip1, a cyclin-dependent kinase inhibitor and a potential mediator of extracellular antimitogenic signals. Cell 78, 59-66 (1994).
38. Fujita, N., Sato, S., Katayama, K. & Tsuruo, T. Akt-dependent phosphorylation of p27Kip1 promotes binding to 14-3-3 and cytoplasmic localization. The Journal of biological chemistry 277, 28706-28713 (2002).
39. Shin, I. et al. PKB/Akt mediates cell-cycle progression by phosphorylation of p27(Kip1) at threonine 157 and modulation of its cellular localization. Nature medicine 8, 1145-1152 (2002).
40. Schopfer, F. J. et al. Nitrolinoleic acid: An endogenous peroxisome proliferator-Activated receptor gamma ligand. P Natl Acad Sci USA 102, 2340-2345 (2005).
41. Freeman, B. A. et al. Nitro-fatty acid formation and signaling. The Journal of biological chemistry 283, 15515-15519 (2008).
42. Schopfer, F. J. et al. Covalent peroxisome proliferator-Activated receptor gamma adduction by nitro-fatty acids: selective ligand activity and anti-diabetic signaling actions. The Journal of biological chemistry 285, 12321-12333 (2010).
43. Arner, E. et al. Adipose tissue microRNAs as regulators of CCL2 production in human obesity. Diabetes 61, 1986-1993 (2012).
44. Acin-Perez, R. et al. ROS-Triggered phosphorylation of complex II by Fgr kinase regulates cellular adaptation to fuel use. Cell Metab 19, 1020-1033 (2014).
45. Zhang, H. H. et al. Insulin stimulates adipogenesis through the Akt-TSC2-mTORC1 pathway. PLoS One 4, e6189 (2009).
46. Molchadsky, A. et al. p53 plays a role in mesenchymal differentiation programs, in a cell fate dependent manner. PLoS One 3, e3707 (2008).
47. Du, Y., Zhang, H., Lu, J. & Holmgren, A. Glutathione and glutaredoxin act as a backup of human thioredoxin reductase 1 to reduce thioredoxin 1 preventing cell death by aurothioglucose. The Journal of biological chemistry 287, 38210-38219 (2012).
48. Mandal, P. K. et al. System x(c)-And thioredoxin reductase 1 cooperatively rescue glutathione deficiency. The Journal of biological chemistry 285, 22244-22253 (2010).
49. Zhang, J. et al. Selective disruption of PPARgamma 2 impairs the development of adipose tissue and insulin sensitivity. P Natl Acad Sci USA 101, 10703-10708 (2004).
50. Enerback, S. The origins of brown adipose tissue. N Engl J Med 360, 2021-2023 (2009).
51. Tormos, K. V. et al. Mitochondrial complex III ROS regulate adipocyte differentiation. Cell Metab 14, 537-544 (2011).
52. Lee, H., Lee, Y. J., Choi, H., Ko, E. H. & Kim, J. W. Reactive oxygen species facilitate adipocyte differentiation by accelerating mitotic clonal expansion. The Journal of biological chemistry 284, 10601-10609 (2009).
53. Menon, S. G. et al. Redox regulation of the G1 to S phase transition in the mouse embryo fibroblast cell cycle. Cancer research 63, 2109-2117 (2003).
54. Ibanez, I. L. et al. H2O2 scavenging inhibits G1/S transition by increasing nuclear levels of p27KIP1. Cancer letters 305, 58-68 (2011).
55. Burhans, W. C. & Heintz, N. H. The cell cycle is a redox cycle: linking phase-specific targets to cell fate. Free radical biology & medicine 47, 1282-1293 (2009).
56. Rassidakis, G. Z. et al. Inhibition of Akt increases p27Kip1 levels and induces cell cycle arrest in anaplastic large cell lymphoma. Blood 105, 827-829 (2005).
57. Ushio-Fukai, M. et al. Reactive oxygen species mediate the activation of Akt/protein kinase B by angiotensin II in vascular smooth muscle cells. The Journal of biological chemistry 274, 22699-22704 (1999).
58. Hou, J. et al. Reactive oxygen species-mediated activation of the Src-epidermal growth factor receptor-Akt signaling cascade prevents bortezomib-induced apoptosis in hepatocellular carcinoma cells. Molecular medicine reports 11, 712-718 (2015).
59. Berger, J. & Moller, D. E. The mechanisms of action of PPARs. Annu Rev Med 53, 409-435 (2002).
60. Ramaswamy, S. et al. Regulation of G1 progression by the PTEN tumor suppressor protein is linked to inhibition of the phosphatidylinositol 3-kinase/Akt pathway. P Natl Acad Sci USA 96, 2110-2115 (1999).
61. Van Harmelen, V., Skurk, T. & Hauner, H. Primary culture and differentiation of human adipocyte precursor cells. Methods Mol Med 107, 125-135 (2005).
62. Lorente-Cebrian, S. et al. MicroRNAs regulate human adipocyte lipolysis: effects of miR-145 are linked to TNF-Alpha. PLoS One 9, e86800 (2014).
63. Gimenez-Cassina, A. et al. Regulation of hepatic energy metabolism and gluconeogenesis by BAD. Cell Metab 19, 272-284 (2014).
64. Simarro, M. et al. Fast kinase domain-containing protein 3 is a mitochondrial protein essential for cellular respiration. Biochem Biophys Res Commun 401, 440-446 (2010).
65. Riddles, P. W., Blakeley, R. L. & Zerner, B. Reassessment of Ellmans reagent. Methods in enzymology 91, 49-60 (1983).
66. Lorente-Cebrian, S. et al. Allograft inflammatory factor 1 (AIF-1) is a new human adipokine involved in adipose inflammation in obese women. BMC Endocr Disord 13, 54 (2013).
67. Kaaman, M. et al. Strong association between mitochondrial DNA copy number and lipogenesis in human white adipose tissue. Diabetologia (2007).
68. Hoffstedt, J., Arvidsson, E., Sjolin, E., Wahlen, K. & Arner, P. Adipose tissue adiponectin production and adiponectin serum concentration in human obesity and insulin resistance. J Clin Endocrinol Metab 89, 1391-1396 (2004).
69. Belarbi, Y. et al. MicroRNA-193b Controls Adiponectin Production in Human White Adipose Tissue. J Clin Endocrinol Metab 100, E1084-1088 (2015).
70. Zhang, X. et al. Disruption of the mitochondrial thioredoxin system as a cell death mechanism of cationic triphenylmethanes. Free radical biology & medicine 50, 811-820 (2011).